RxDoctor Payments Data

Chitra Safaya, MD

Infectious Disease · San Diego, CANPI 1568624336

Payments from drug & device makers

$153in general payments, 2019–2025

Across 7 payments — averaging $21.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$63
  • Alnylam Pharmaceuticals Inc.$32
  • Mylan Specialty L.p.$22
  • Pfizer$21
  • Sanofi Pasteur Inc.$15

What the payments were for

  • Food & beverage$153100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$153 in reported general payments places this provider in the 35th percentile of 856 infectious disease providers in California.

See all infectious disease providers in California

Medicare billing

Part B allowed, 2024
$326,353
Medicare patients
544
Services billed
3,225

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CeftriaxoneCeftriaxone Sodium19$1,391

Paid to pharmacies, not to this prescriber.

Other infectious disease in San Diego

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →